Clinical Trial Update: Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders [NA]

View source ↗

Summary

Completed trial evaluating reduced-intensity hematopoietic stem cell transplantation for high-risk lysosomal storage diseases and peroxisomal disorders. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lysosomal Storage Disease
• Peroxisomal Disorder

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Lysosomal Storage Disease, Peroxisomal Disorder | NA | Status: COMPLETED | Results posted: 2016-10-11